Market Cap

Sierra Oncology, Inc. Market Capitalization:

$1.34 Billion

USD as of June 1, 2022

business Sierra Oncology, Inc. Company Profile

Sierra Oncology, Inc. Main Stock Listing

NASDAQ: SRRA

Market Capitalization History of Sierra Oncology, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Sierra Oncology, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2022 $659.1 M 86.40%
Jan. 1, 2021 $353.6 M 19.57%
Jan. 1, 2020 $295.7 M -77.74%
Jan. 1, 2019 $1.33 B -55.41%
Jan. 1, 2018 $2.98 B 121.01%
Jan. 1, 2017 $1.35 B -83.33%
Jan. 1, 2016 $8.09 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Sell the task first.
Automate what repeats.
Publish a paid offer in minutes. Learn what buyers actually pay for before building agents, workflows, or services nobody buys.
Get Started Free
For AI operators, consultants, & service builders

Sierra Oncology, Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Sierra Oncology, Inc. has the following listings and related stock indices.


Stock: NASDAQ: SRRA

Stock: FSX: P7N1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.